Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2001
10/25/2001WO2001079477A2 Identification, isolation and use of a wheat storage protein gene variant
10/25/2001WO2001079476A1 Lactic acid bacteria overproducing exopolysaccharides
10/25/2001WO2001079472A2 Nucleic acid sequences to proteins involved in tocopherol synthesis
10/25/2001WO2001079471A2 Self-extinguishing recombinases, nucleic acids encoding them and methods of using the same
10/25/2001WO2001079469A2 Cloning of corynebacteriaceae histidine ammonia lyase and therapeutic uses
10/25/2001WO2001079468A2 Drug metabolizing enzymes
10/25/2001WO2001079467A2 Identification of a renal nadph oxidase
10/25/2001WO2001079466A2 Regulation of human epithin-like serine protease
10/25/2001WO2001079465A2 Nucleic acids encoding polypeptides having haloperoxidase activity
10/25/2001WO2001079462A2 Nucleic acids encoding polypeptides having haloperoxidase activity
10/25/2001WO2001079461A2 Polypeptides having haloperoxidase activity
10/25/2001WO2001079459A2 Polypeptides having haloperoxidase activity
10/25/2001WO2001079455A1 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN
10/25/2001WO2001079454A1 Novel compounds
10/25/2001WO2001079448A2 Trp8, a transient receptor potential channel expressed in taste receptor cells
10/25/2001WO2001079445A2 Pluripotent cells comprising allogenic nucleus and mitochondria
10/25/2001WO2001079444A2 Albumin fusion proteins
10/25/2001WO2001079443A2 Albumin fusion proteins
10/25/2001WO2001079442A2 Albumin fusion proteins
10/25/2001WO2001079441A2 Gene inactivation by targeted dna methylation
10/25/2001WO2001079440A2 Extracellular expression of pectate lyase using bacillus or escherichia coli
10/25/2001WO2001079439A2 A novel polypeptide, a human cannabinoid receptor protein 19 and the polynucleotide encoding the polypeptide
10/25/2001WO2001079420A2 Detection and amplification or rna using target-mediated ligation of dna by rna ligase
10/25/2001WO2001079419A2 Cellular arrays for the identification of altered gene expression
10/25/2001WO2001079299A1 Enhancement of antibody-mediated immune responses
10/25/2001WO2001079298A1 Novel recombinant antibodies, amino acid sequences of cdrs thereof and genes encoding the same
10/25/2001WO2001079296A1 Humar emr2, a g-protein coupled receptor from the egf-tm7 family
10/25/2001WO2001079294A2 Human proteins, polynucleotides encoding them and methods of using the same
10/25/2001WO2001079291A2 Secreted proteins
10/25/2001WO2001079289A2 Human interferon, zinf2
10/25/2001WO2001079286A2 Compositions and methods for the therapy and diagnosis of breast cancer
10/25/2001WO2001079284A2 Therapeutic compounds and methods for formulating v3, a versican isoform
10/25/2001WO2001079282A2 Molecules associated with human reproduction
10/25/2001WO2001079281A1 Sheep lice, bovicola ovis, allergen treatment
10/25/2001WO2001079280A1 A novel polypeptide - human ccr4 protein 16 and the polynucleotide encoding said polypeptide
10/25/2001WO2001079279A1 A novel polypeptide-homo tnf receptor-associated factors 16 and polynucleotide encoding said polypeptide
10/25/2001WO2001079275A2 STAPHYLOCOCCAL GENE, vgaC, CONFERRING RESISTANCE TO STREPTOGRAMIN A AND RELATED COMPOUNDS
10/25/2001WO2001079273A2 Viruses comprising mutated ion channel protein
10/25/2001WO2001079272A2 Sitosterolemia susceptibility gene (ssg): compositions and methods of use
10/25/2001WO2001079271A1 Albumin fusion proteins
10/25/2001WO2001079269A2 Lipid binding protein 4
10/25/2001WO2001079266A1 Antibody against human kgfr
10/25/2001WO2001079265A1 Antibody against human kgf
10/25/2001WO2001079259A1 Javelinization of protein antigens to heat shock proteins
10/25/2001WO2001079258A1 Albumin fusion proteins
10/25/2001WO2001079257A2 Multidrug resistance (mdr) efflux pump polypeptides
10/25/2001WO2001079253A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
10/25/2001WO2001079249A2 Peptide nucleic acid derivatives with a negative charge, agents and methods for producing them
10/25/2001WO2001078896A2 Purification apparatus and method
10/25/2001WO2001078894A2 Novel human gene relating to respiratory diseases, obesity, and inflammatory bowel disease
10/25/2001WO2001078796A1 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
10/25/2001WO2001078790A2 GENE THERAPHY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING A β2ADRENERGIC RECEPTOR GENE
10/25/2001WO2001078789A2 Poliovirus replicons encoding therapeutic agents and uses thereof
10/25/2001WO2001078772A1 Heat shock protein-based antiviral vaccines
10/25/2001WO2001078768A2 Targeted vaccine delivery systems
10/25/2001WO2001078757A2 Reversible immortalization
10/25/2001WO2001078756A2 Agent for postoperative use after the removal of bone tumours
10/25/2001WO2001078755A2 A novel polypeptide - human ataxia-telangiectasia mutant protein 9 and a polynucleotide encoding the same
10/25/2001WO2001078753A2 Therapeutic uses for mesenchymal stromal cells
10/25/2001WO2001078655A2 Methods and compositions for heat shock protein mediated immunotherapy of melanoma
10/25/2001WO2001078503A2 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/25/2001WO2001056596A8 Use of lysosomal acid lipase for treating atherosclerosis and related diseases
10/25/2001WO2001040512A3 Resistance gene
10/25/2001WO2001040499A3 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses
10/25/2001WO2001039786A3 New uses of suppressive macrophage activation factors
10/25/2001WO2001038584A3 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
10/25/2001WO2001036636A3 Human notch ligand proteins and polynucleotides encoding the same
10/25/2001WO2001036603A3 Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
10/25/2001WO2001030489A3 Device and method for hybridizing double-stranded dna samples on oligomer arrays
10/25/2001WO2001027159A3 Polypeptides for detection and elimination of ca19-9 antigen positive cells
10/25/2001WO2001024684A3 Methods for treatment of solid tumors and metastasis by gene therapy
10/25/2001WO2001023597A3 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
10/25/2001WO2001023583A3 Thermostable enzyme promoting the fidelity of thermostable dna polymerases- for improvement of nucleic acid synthesis and amplification in vitro
10/25/2001WO2001023570A3 Methods and compositions relating to sodium channel beta-1a subunits
10/25/2001WO2001023421A3 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
10/25/2001WO2001022092A3 Method to identify compounds which modulate fra-1 expression fils
10/25/2001WO2001021838A3 Three-dimensional microarray system for parallel genotyping of single nucleotide polymorphisms
10/25/2001WO2001021794A3 Smad associating polypeptides
10/25/2001WO2001019982A3 Micro-organisms, their use and method for producing d-amino acids
10/25/2001WO2001018252A3 Methods for disease detection
10/25/2001WO2001012790A3 Isomerase proteins
10/25/2001WO2001012663A3 Hematopoietic regulatory factors and methods of use thereof
10/25/2001WO2001012126A3 Cardiomyocyte regeneration
10/25/2001WO2001006017A3 Methods for preparing quantities of preselected polynucleotide sequences and uses thereof
10/25/2001WO2001005986A3 Mites-like element and transcriptional activation element
10/25/2001WO2001005957A3 Grapevine leafroll-associated virus proteins
10/25/2001WO2001000805A3 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
10/25/2001WO2000054573A9 Geminivirus resistant transgenic plants
10/25/2001WO2000053812A9 Replica amplification of nucleic acid arrays
10/25/2001WO2000047618A9 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
10/25/2001WO2000043492A9 Method of site specific labeling of proteins and uses therefor
10/25/2001WO2000040741A9 Lentivirus vector system
10/25/2001WO2000011169A3 Human cell signaling proteins (csig)
10/25/2001WO1999057267A3 Human epididymal glytathione peroxidase
10/25/2001US20010034888 Transforming plants with nucleic acid constructs encoding sense-strand untranslatable rna molecules and/or double stranded rna molecules, rna molecules that are similar to (not identical to) certain agrobacterium tumor-inducing genes
10/25/2001US20010034887 Transformation of guar
10/25/2001US20010034886 Rad2/FEN-1 orthologues and uses thereof
10/25/2001US20010034885 Non-human animal deficient in function of pituitary adenylate cyclase-activating polypeptide gene
10/25/2001US20010034884 Abeta-peptide screening assay
10/25/2001US20010034439 Transcriptional unit complementary to human telomerase RNA sequence linked to regulating sequences
1 ... 2955 2956 2957 2958 2959 2960 2961 2962 2963 2964 2965 2966 2967 2968 2969 2970 2971 2972 2973 2974 2975 ... 4023